Physician profile
Patrick Ryan Parsell
NPI 1104438563
$4,458.42
in general payments reported to CMS, 2019-2025
9 companies · $2,441 in 2025
The $2,441 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $447 · 2023: $618 · 2024: $713 · 2025: $2,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,816 · Travel and Lodging: $663 · Consulting Fee: $270 · Education: $24.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.59 |
| Travel and Lodging | $662.87 |
| Consulting Fee | $270.00 |
| Education | $24.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,700.90 | 2021-2025 | Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,345.54 | 2023-2025 | Yeztugo, Descovy, Biktarvy |
| Merck Sharp & Dohme LLC | $157.95 | 2023-2025 | Lagevrio, Delstrigo, Dificid |
| Dynavax Technologies Corporation | $108.21 | 2022 | |
| Avion Pharmaceuticals | $43.19 | 2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $32.86 | 2023 | |
| Abbvie INC. | $24.00 | 2022 | |
| Evofem Biosciences, INC. | $23.80 | 2022 | |
| Therapeuticsmd, INC. | $21.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Parsell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.